We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Cervicovaginal DNA Virome Alterations Associated with Genital Inflammation

By LabMedica International staff writers
Posted on 08 Apr 2022
Print article
Image: The cobas 4800 HPV test and the cobas HPV test for use on cobas 68/8800 systems are clinically validated and FDA approved (Photo courtesy of Roche Diagnostics)
Image: The cobas 4800 HPV test and the cobas HPV test for use on cobas 68/8800 systems are clinically validated and FDA approved (Photo courtesy of Roche Diagnostics)

Cervical cancer is one of the most common cancers among women. In 2021, more than 600,000 cases and 340,000 deaths were reported worldwide. In addition to infection with the human papillomavirus (HPV), known risk factors for cervical cancer include immunodeficiency, smoking and oral contraceptive use.

The healthy vaginal bacterial microbiome is dominated by Lactobacillus species. Bacterial vaginosis, characterized by low Lactobacillus abundance and overrepresentation of anaerobes, including Gardnerella, Prevotella, Atopobium, Sneathia, Megasphaera, and others, has been associated with HPV infection and cervical intraepithelial neoplasia.
Medical Scientists at the Arizona State University (Temple, AZ, USA) included in a study a subset of 28 premenopausal, non-pregnant women. Vaginal swabs and cervicovaginal lavage (CVL) samples were collected by a physician. The first vaginal swab was collected using an Eswab collection system with Amies transport medium (Copan Diagnostics, Murrieta, CA, USA) and used for HPV genotyping and 16S rRNA sequencing analyses. CVL samples were collected using 10 mL of sterile 0.9% saline and used for multiplex cytokine and virome analyses.

Women were classified as HPV negative or positive. HPV status was determined with a linear array HPV genotyping test (Roche Diagnostics, Indianapolis, IN, USA), which detects 37 anogenital HPV genotypes. Vaginal bacterial microbiome analysis was performed previously by 16S rRNA gene sequencing using DNA extracted from vaginal swabs and sequenced for 250 cycles on the MiSeq platform (Illumina, San Diego, CA, USA). A multiplex cytokine assay was performed using Milliplex MAP human cytokine/chemokine and Th17 magnetic bead panels (Millipore, Burlington, MA, USA).

The investigators reported that specific virome alterations were associated with features of the local microenvironment related to HPV persistence and progression to cervical cancer. Cervicovaginal viromes clustered distinctly by genital inflammation state. Genital inflammation was associated with decreased virome richness and alpha diversity and an increased abundance of Anelloviridae species from the genus Alphatorquevirus. Lactobacillus bacteriophages were closely associated with increased Lactobacillus abundance, consistent with phage-host relationships. Interestingly, bacteria-bacteriophage transkingdom interactions were linked to genital inflammation and showed specific interactions with bacterial vaginosis-associated bacteria, including Gardnerella, Prevotella, and Sneathia.

The authors concluded that they had identified associations between cervicovaginal DNA virome composition and bacterial microbiome and genital inflammation. Both vaginal Lactobacillus relative abundance and genital inflammation were associated with changes in the cervicovaginal virome. Anelloviridae species, including Alphatorquevirus species, were also associated with genital inflammation. Additionally, they observed distinct bacteria-bacteriophage transkingdom interactions between established disease-associated bacteria and bacteriophages. The study was published on March 28, 2022 in the journal mSystems.


Related Links:
Arizona State University
Copan Diagnostics
Roche Diagnostics
Millipore
Illumina



 

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Clostridium Difficile Test
VIDITEST C. Difficile Toxin A+B (Card) Rapid Test
New
Thyroid Stimulating Hormone Assay
Neonatal TSH ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The new assays will run on the QIAcuity digital PCR (dPCR) platform (Photo courtesy of QIAGEN)

New Digital PCR Assays Enable Accurate and Sensitive Detection of Critical Pathogens

QIAGEN (Venlo, the Netherlands) has introduced 100 new assays for its QIAcuity digital PCR (dPCR) platform, aimed at advancing research in areas such as cancer, inherited genetic disorders, and infectious... Read more

Pathology

view channel
Image: The new AI technology more precisely predicts the risk of getting breast cancer (Photo courtesy of William Brøns Petersen)

AI Technology Accurately Predicts Breast Cancer Risk Via ‘Zombie Cells’

Breast cancer remains one of the most common cancers worldwide, causing 670,000 deaths in 2022. A key aspect of assessing cancer risk involves identifying dying cells. A new study has demonstrated that... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.